Sphera Funds Management Ltd. Rocket Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

$545 Million
Q3 2024

A detailed history of Sphera Funds Management Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 231,792 shares of RCKT stock, worth $3.27 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

231,792

Previous 206,933 12.01%

Holding current value

$3.27 Million

Previous $4.46 Million 3.91%

% of portfolio

0.79%

Previous 0.65%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $437,518 - $643,350	24,859 Added 12.01%	231,792 $4.28 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $479,539 - $620,197	23,211 Added 12.63%	206,933 $4.46 Million
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $184,715 - $217,055	-7,061 Reduced 3.7%	183,722 $4.95 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $306,352 - $583,128	-18,257 Reduced 8.73%	190,783 $5.72 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $406,287 - $648,388	-26,960 Reduced 11.42%	209,040 $4.28 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $3.73 Million - $5.33 Million	236,000 New	236,000 $4.04 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $3.25 Million - $4.94 Million	-75,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $3.57 Million - $9.12 Million	-153,016 Reduced 67.11%	75,000 $4.11 Million
Q3 2020 Nov 12, 2020	SELL	$20.5 - $28.59 $2.3 Million - $3.2 Million	-112,000 Reduced 32.94%	228,016 $5.21 Million
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $66,600 - $113,050	5,000 Added 1.49%	340,016 $7.12 Million
Q1 2020 May 14, 2020	SELL	$9.71 - $25.11 $260,927 - $674,755	-26,872 Reduced 7.43%	335,016 $4.67 Million
Q4 2019 Feb 13, 2020	SELL	$11.07 - $24.23 $3.3 Million - $7.22 Million	-298,112 Reduced 45.17%	361,888 $8.24 Million
Q3 2019 Nov 14, 2019	BUY	$10.85 - $14.78 $3.8 Million - $5.17 Million	350,000 Added 112.9%	660,000 $7.69 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $299,985 - $396,180	19,999 Added 6.9%	310,000 $0
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $3.25 Million - $6.82 Million	290,001 New	290,001 $4.3 Million
Q3 2018 Nov 14, 2018	SELL	$18.5 - $25.49 $637,787 - $878,767	-34,475 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$14.58 - $23.0 $3.9 Million - $6.16 Million	-267,800 Reduced 88.59%	34,475 $677,000
Q1 2018 May 10, 2018	BUY	$11.68 - $19.19 $3.53 Million - $5.8 Million	302,275 New	302,275 $5.67 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Rocket Pharmaceuticals, Inc. Transaction History